The Importance of the Orphan Drug Tax Credit [Infographic]

Mathew Shanley

The Orphan Drug Tax Credit was established as part of the Orphan Drug Act of 1983.

The Act was signed into law in 1983, making the United States the first country in the world to provide financial incentives for developing treatments for rare diseases. A 2015 study conducted by the National Organization for Rare Disorders concluded that, if the tax credit did not exist, exactly one-third fewer orphan products would be developed.

With this infographic from Rare Disease Report, the impact of the ODTC can be easily seen. These 10 statistics make it obvious why the Tax Credit - and the Orphan Drug Act as a whole - are both so important to the rare disease community.

Rare Disease Report For more information on Rare Diseases, be sure to follow Rare Disease Report on Facebook and Twitter.
Printer Printing...